Oncology specialists from UC San Francisco will present new clinical research findings and cutting-edge treatment strategies at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, ...

STEM undergraduate researchers presented their latest scientific findings during the annual Undergraduate Research Symposium ...

The Bioinformatics department under Agricultural Engineering and Technology Faculty of Bangladesh Agriculture University (BAU ...

Verismo Therapeutics, a clinical-stage CAR T company pioneering the KIR-CAR platform, today provided additional details on ...

Additionally, two late-breaking posters have been accepted presenting ... Abstract Details: Pharmaceutical Pipeline Presentation (ASCP) Presentation Title: Safety and Efficacy of GH001 in ...

Ateganosine (THIO, 6-thio-dG or 6-thio-2’-deoxyguanosine) is a first-in-class investigational telomere-targeting agent currently in clinical development to evaluate its activity in non-small ...

From scholarly lectures to TED-style talks, from academic posters to interactive workshops, we engage with audiences ranging from field experts to the general public. This multi-faceted approach to ...

today announced its abstract has been selected for a poster presentation at the 2025 European Hematology Association Annual Meeting (EHA) being held June 12-15 in Milan, Italy. The abstract ...

were selected for a poster presentation at the European Hematology Association (EHA) 2025 Congress, taking place June 12–15 in Milan, Italy. The presentation will highlight emerging safety ...

MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic diseases, announced ...

Poster 1040: Preclinical Efficacy and Potency Assay Development of An Optimized AAV-hUPF1 Gene Therapy for Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD) Amyotrophic lateral ...

today announced the Company will exhibit four poster presentations at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting, which is being held from May 13-17, 2025 ...